Evidence map›Paper›PMID 20567598›Full record

ArticlePloS one2010

Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase.

Hsiang-Chin Chen, Jia Xie, Zheng Zhang, Li-Ting Su, Lixia Yue, Loren W Runnels

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Mapping TRPM7 Function by NS8593.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Visualization of mechanical stress-mediated CaBioscience of microbiota, food and health · 2020
    Article
  8. CaJournal of cardiovascular development and disease · 2019
    Review
  9. Role of the chanzyme TRPM7 in the nervous system in health and disease.Cellular and molecular life sciences : CMLS · 2019
    Review
  10. Article
  11. Role of TRPM7 in cerebral ischaemia and hypoxia.The Journal of physiology · 2017
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hsiang-Chin ChenDepartment of Pharmacology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, USA.
Jia Xie
Zheng Zhang
Li-Ting Su
Lixia Yue
Loren W Runnels
UConn Health · US

Funding

Ca2+ signaling mechanisms in cardiac fibrosisR01HL078960 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YUE, LIXIA · 2005 to 2015
$3.9M
Functional Analysis of the Bifunctional Ion Channel and Kinase TRPM7R01GM080753 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RUNNELS, LOREN W · 2007 to 2016
$3.0M
NHLBI NIH HHS HL078960NHLBI NIH HHS R01 HL078960NIGMS NIH HHS 1R01GM080753NIGMS NIH HHS R01 GM080753
6 · The paper itself

Abstract

TRPM7 is a ubiquitous divalent-selective ion channel with its own kinase domain. Recent studies have shown that suppression of TRPM7 protein expression by RNA interference increases resistance to ischemia-induced neuronal cell death in vivo and in vitro, making the channel a potentially attractive pharmacological target for molecular intervention. Here, we report the identification of the 5-lipoxygenase inhibitors, NDGA, AA861, and MK886, as potent blockers of the TRPM7 channel. Using a cell-based assay, application of these compounds prevented cell rounding caused by overexpression of TRPM7 in HEK-293 cells, whereas inhibitors of 12-lipoxygenase and 15-lipoxygenase did not prevent the change in cell morphology. Application of the 5-lipoxygenase inhibitors blocked heterologously expressed TRPM7 whole-cell currents without affecting the protein's expression level or its cell surface concentration. All three inhibitors were also effective in blocking the native TRPM7 current in HEK-293 cells. However, two other 5-lipoxygenase specific inhibitors, 5,6-dehydro-arachidonic acid and zileuton, were ineffective in suppressing TRPM7 channel activity. Targeted knockdown of 5-lipoxygenase did not reduce TRPM7 whole-cell currents. In addition, application of 5-hydroperoxyeicosatetraenoic acid (5-HPETE), the product of 5-lipoxygenase, or 5-HPETE's downstream metabolites, leukotriene B4 and leukotriene D4, did not stimulate TRPM7 channel activity. These data suggested that NDGA, AA861, and MK886 reduced the TRPM7 channel activity independent of their effect on 5-lipoxygenase activity. Application of AA861 and NDGA reduced cell death for cells overexpressing TRPM7 cultured in low extracellular divalent cations. Moreover, treatment of HEK-293 cells with AA861 increased cell resistance to apoptotic stimuli to a level similar to that obtained for cells in which TRPM7 was knocked down by RNA interference. In conclusion, NDGA, AA861, and MK886 are potent blockers of the TRPM7 channel capable of attenuating TRPM7's function during cell stress, making them effective tools for the biophysical characterization and suppression of TRPM7 channel conductance in vivo.

Indexed as

Lipoxygenase InhibitorsArachidonate 5-LipoxygenaseBase SequenceCell DeathCell LineGene Knockdown TechniquesHumansProtein Serine-Threonine KinasesRNA, Small InterferingTRPM Cation ChannelsArachidonate 5-LipoxygenaseLipoxygenase InhibitorsProtein Serine-Threonine KinasesRNA, Small InterferingTRPM7 protein, humanTRPM Cation Channels

Identifiers

PMID20567598
PMCPMC2887440
OpenAlexW2056428844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.